T25-55641-50320
2 vaccinations
1 coded response
2 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 360 / AL
- Registered
- 2021-06-04
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-30
Dose 1 — Pfizer-BioNTech
-
2021-04-20
Dose 2 — Pfizer-BioNTech
-
2021-06-04
Registered in v-safe
-
2021-06-04
Survey response — day 42, dose 2MedDRA: Condition aggravated, Immune thrombocytopenia, Pre-existing disease — Feeling: FairFree text: Relapse of ITPMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-30 | Pfizer-BioNTech | |
| 2 | 2021-04-20 | Pfizer-BioNTech |
Free text
Release 8 — day 42, dose 2
Symptoms: Relapse of ITP
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Condition aggravated | ✓ | ✓ | ✓ |
| SD | Immune thrombocytopenia | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release